About the American council of cannabis medicine

  About the American Council of Cannabis Medicine  

  The American Council of Cannabis Medicine (ACCM) is the national trade group whose purpose is advocating and serving as the voice for the medical-cannabis industry in Washington, D.C., and supporting emerging medical-cannabis states. The Council’s mission is to: influence important legislative and regulatory policies and government programs that affect medical cannabis; communicate with Washington DC and state policymakers and the media about medical-cannabis, usage, research, processing and products; affect domestic policy to maintain and expand opportunities for U.S. patients, providers, and physicians; and enhance, promote and protect the image and reputation of this newly emerging vital industry.   

 ACCM member organizations are industry producer/processors, medical-cannabis pharmacies and dispensaries, practicing physician groups, patient, customer/client user-related groups, traditional pharma companies, and allied industry firms. The producer/processors account for most of the medical cannabis produced in state-licensed programs. ACCM was established in 2016 as a working group of stakeholders and has become a full stand-alone public-facing organization just a few years later. ACCM maintains headquarters in the nation’s capital to provide a permanent voice exclusively for medical cannabis and to better represent the industry and its emerging products as serious medical solutions supporting ongoing clinical research and advancements.  

Please call us with any questions:

American Council of Cannabis Medicine

601 Pennsylvania Ave. NW

South Building, Suite 900

Washington, D.C., 20004 

United States of America 

202-349-9650